Oncaspar
Total Payments
$386,828
Transactions
119
Doctors
94
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $313,219 | 54 | 40 |
| 2023 | $73,609 | 65 | 57 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $368,536 | 14 | 95.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,220 | 2 | 2.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,290 | 1 | 1.6% |
| Food and Beverage | $3,051 | 99 | 0.8% |
| Travel and Lodging | $731.85 | 3 | 0.2% |
Payments by Type
Research
$368,536
14 transactions
General
$18,292
105 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A single Arm Phase 1b study of hyper-CVAD plus Asparlas in youngadults (18-50) with newly diagnosed ALL | Servier BioInnovation | $304,169 | 0 |
| Total therapy study XVII (TOTXVII) for newly diagnosed patients with acute lymphoblastic leukemia and lymphoma | Servier BioInnovation | $64,367 | 0 |
Top Doctors Receiving Payments for Oncaspar
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Memphis, TN | $368,536 | 14 |
| , M.D | Hematology | New York, NY | $7,206 | 7 |
| , MD | Pediatric Hematology-Oncology | Memphis, TN | $5,500 | 1 |
| Wendy Stock | Hematology & Oncology | Chicago, IL | $2,720 | 1 |
| , CPNP-PC | Pediatrics | Phoenix, AZ | $135.32 | 1 |
| , MD | Pediatric Hematology-Oncology | Phoenix, AZ | $135.32 | 1 |
| , M.D | Pediatric Hematology-Oncology | Phoenix, AZ | $135.32 | 1 |
| , MD | Pediatric Hematology-Oncology | Phoenix, AZ | $135.32 | 1 |
| , DNP-PNP | Pediatrics | Phoenix, AZ | $135.32 | 1 |
| , PNP | Pediatrics | Phoenix, AZ | $135.32 | 1 |
| , DO | Pediatric Hematology-Oncology | Phoenix, AZ | $135.32 | 1 |
| , NP | Nurse Practitioner | Stanford, CA | $48.60 | 2 |
| , NP | Gerontology | Palo Alto, CA | $48.60 | 2 |
| , MD | Student in an Organized Health Care Education/Training Program | Henderson, NV | $47.76 | 2 |
| , FNP-BC | Family | Dallas, TX | $44.73 | 2 |
| , MD | Hematology & Oncology | Celebration, FL | $43.76 | 1 |
| , M.D | Specialist | San Francisco, CA | $42.80 | 2 |
| , ANP-BC | Adult Health | Hilton Head Island, SC | $26.13 | 1 |
| Casey Debias | Primary Care | Chicago, IL | $25.68 | 1 |
| Radhika Peddinti | Pediatric Hematology-Oncology | Chicago, IL | $25.68 | 1 |
| , MD | Pediatrics | Saint Louis, MO | $25.68 | 1 |
| , NP | Nurse Practitioner | Palo Alto, CA | $24.89 | 1 |
| , NP | Adult Health | Duarte, CA | $24.89 | 1 |
| , NP | Adult Health | San Francisco, CA | $24.89 | 1 |
| , APRN | Gerontology | Houston, TX | $24.65 | 1 |
Ad
Manufacturing Companies
- Servier BioInnovation $368,536
- SERVIER PHARMACEUTICALS LLC $10,072
- SERVIER AFFAIRES MEDICALES $8,220
Product Information
- Type Drug
- Total Payments $386,828
- Total Doctors 94
- Transactions 119
About Oncaspar
Oncaspar is a drug associated with $386,828 in payments to 94 healthcare providers, recorded across 119 transactions in the CMS Open Payments database. The primary manufacturer is Servier BioInnovation.
Payment data is available from 2023 to 2024. In 2024, $313,219 was paid across 54 transactions to 40 doctors.
The most common payment nature for Oncaspar is "Unspecified" ($368,536, 95.3% of total).
Oncaspar is associated with 2 research studies, including "A single Arm Phase 1b study of hyper-CVAD plus Asparlas in youngadults (18-50) with newly diagnosed ALL" ($304,169).